CD38 and COVID-19: As reported [27], the transitional differentiation of naive into effector/memory T cells co-expressing CD38+HLA-DR+ among CD8+T cells is a hallmark of COVID-19 that persisted in LVS compared to controls and SVS (P = 0.002 and P = 0.012) (Fig. S8C, D).